Cerebral achromatopsia

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Cerebral achromatopsia
Synonyms	N/A
Pronounce	N/A
Specialty	N/A
Symptoms	Loss of color vision, visual agnosia
Complications	N/A
Onset	Sudden, typically after stroke or brain injury
Duration	Permanent
Types	N/A
Causes	Damage to the ventral stream of the visual cortex
Risks	Stroke, traumatic brain injury
Diagnosis	Neuroimaging, visual field test
Differential diagnosis	Color blindness, visual agnosia
Prevention	N/A
Treatment	None specific; occupational therapy
Medication	N/A
Prognosis	Variable, often permanent
Frequency	Rare
Deaths	N/A

Cerebral achromatopsia is a type of color blindness that is caused by damage to the cerebral cortex of the brain, rather than abnormalities in the eyes themselves. This condition is also known as cortical color blindness or central achromatopsia. Unlike typical color blindness, which is often inherited and affects the way light is processed by the retina, cerebral achromatopsia arises from physical damage to the brain, particularly the area responsible for processing color information, known as the V4 visual area.

Causes

Cerebral achromatopsia can result from various causes, including stroke, traumatic brain injury, and infectious diseases that affect the brain. The condition specifically involves damage to the V4 visual area of the brain, which is crucial for color vision. This area is located in the occipital lobe, which is part of the cerebral cortex involved in visual processing.

Symptoms

Individuals with cerebral achromatopsia experience a range of symptoms related to color perception. The most prominent symptom is a difficulty or inability to perceive colors. Patients may see the world in shades of gray, or they may have trouble distinguishing between certain colors. Other symptoms can include:

• Difficulty recognizing faces (prosopagnosia)
• Problems with visual object recognition (visual agnosia)
• Reduced visual acuity and contrast sensitivity

Diagnosis

Diagnosis of cerebral achromatopsia involves a comprehensive evaluation that includes a medical history, neurological examination, and specialized tests to assess color vision and brain function. Magnetic resonance imaging (MRI) or computed tomography (CT) scans may be used to identify damage to the V4 visual area or other parts of the brain.

Treatment

There is no cure for cerebral achromatopsia, but patients can benefit from rehabilitation strategies that help them adapt to their color vision deficiencies. These may include using high-contrast items, special lighting, or software that adjusts the colors on computer and smartphone screens to enhance visibility. In some cases, therapy with a neuropsychologist or occupational therapist may be recommended to help individuals adjust to changes in their vision and improve their quality of life.

Prognosis

The prognosis for cerebral achromatopsia varies depending on the extent of the brain damage and the individual's response to rehabilitation. Some patients may experience improvements in their color vision over time, especially if the brain damage is mild and other areas of the brain can compensate for the loss of function in the V4 visual area. However, for many individuals, the color vision impairments may be permanent.

See also

• Color blindness
• Visual cortex
• Occipital lobe
• Visual agnosia
• Prosopagnosia